TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative ...

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of ...

Researchers at Yale have achieved a major breakthrough in synthetic biology. They have rewritten the genetic code of an ...

John Glass, leader of the JCVI’s synthetic-biology programme ... work might sound straightforward — simply substituting one codon for another — but genome recoding requires much planning ...

Alltrna’s CEO Michelle Warner said that the approach allows for basket trials that can group patients with different diseases ...

This study presents an important discovery regarding the diversity and evolution of gall-forming microbial effectors. Supported by convincing computational structural predictions and analyses, the ...

Almirall as European leader in Medical Dermatology: we delivered impactful products to more patients and the medical community. Our double-digit sales growth and increased profitability demonstrate ...

However, by comparing datasets of mammoth and elephant genomes, the team identified that mammoths lost the function of one of these genes. The researchers also introduced mutations into two of the ...

This study demonstrates the critical role of Afadin on the generation and maintenance of complex cellular layers in the mouse retina. The data are solid, which provides important insights into how ...

The bacterium chlamydia trachomatis is a major cause of sexually transmitted diseases. Bacteria have lots of tricks up their sleeve that help them survive inside cells. One strategy that chlamydia ...